Cardiovascular risk factors play greater role in adverse outcomes in thymic cancer patients
Thymic cancer, a rare type of cancer that has brought patients to Indiana University Health in recent years for treatment, has become the subject of further study between investigators from the Krannert Cardiovascular Research Center and the Melvin and Bren Simon Comprehensive Cancer Center at Indiana University School of Medicine, and collaborators at Regenstrief Institute. The researchers wanted to explore cardiovascular risk factors for adverse outcomes among people with and without thymic cancer. Results of their study was published in Frontiers.
Internationally recognized authority on cancer research and genome organization Feng Yue, PhD, to speak April 28
Feng Yue, PhD, a renowned scientist from Northwestern University’s Feinberg School of Medicine, will speak at Indiana University School of Medicine on April 28. Open
Navigating adversity to advance medicine: The inspiring journey of Rada Malko
Read the inspiring story of how Rada Malko overcame the adversities of being a young immigrant to becoming an accomplished student at the IU School
Narrative medicine: IU oncologist uses storytelling to promote humanism in medical practice
Laura Vater, MD, MPH, uses storytelling to promote humanism in medicine, focusing on wellbeing of both physicians and their patients.
Landrum is first woman to lead OB-GYN department at IU
Gynecologic oncologist Lisa Landrum, MD, PhD, is the new chair for obstetrics and gynecology. A former athlete and coach, Landrum emphasizes cooperation and inclusion on
From personal loss to professional purpose: Fishel’s impact on pancreatic cancer research
Driven by personal loss and a passion for science, Melissa L. Fishel, PhD, works on developing therapies for pancreatic and other hard-to-treat cancers while also
IU School of Medicine hosts national conference on technology in cancer research
IU School of Medicine will host the 2024 annual meeting of the NIH/NCI program for Informatics Technology for Cancer Research highlighting emerging technology tools for
Beyond testis cancer: Koch led IU urology to national prominence with expanded faculty expertise
During his 26 years as urology chair at IU School of Medicine, Michael Koch, MD, quadrupled the department's faculty, adding expertise and making IU's urology
Adra’s impact: IU genitourinary oncologist named to IBJ ‘Forty Under 40’
Nabil Adra, MD, was named to the IBJ 2024 Forty Under 40 for his work in genitourinary cancer treatment and research. He aims to carry
IU School of Medicine enrolls 100th patient in 23-site brain tumor radiation therapy clinical trial
Indiana University School of Medicine is one of 23 institutions in the Radiation One and Done Study (ROADS) clinical trial, and the university, in conjunction with